Bain Capital Public Equity Management II’s Sanofi SNY Stock Holding History

Bain Capital Public Equity Management II’s Portfolio SNY Stock Details SNY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q3	–	Sell	-1,487,800	Closed	-$74.4M	–	50
2022 Q2	$74.4M	Buy	1,487,800 +503,452	+51%	+$26.7M	3.66%	13
2022 Q1	$50.5M	Buy	984,348 +572,780	+139%	+$29.6M	1.62%	28
2021 Q4	$20.6M	Sell	411,568 -161,476	-28%	-$7.99M	0.69%	31
2021 Q3	$27.6M	Sell	573,044 -36,944	-6%	-$1.88M	0.97%	28
2021 Q2	$32.1M	Buy	609,988 +146,065	+31%	+$7.62M	1.37%	23
2021 Q1	$22.9M	Buy	463,923 +370,173	+395%	+$17.8M	0.96%	30
2020 Q4	$4.55M	Sell	93,750 -155,419	-62%	-$7.67M	0.23%	36
2020 Q3	$12.5M	Buy	249,169 +46,027	+23%	+$2.37M	0.83%	28
2020 Q2	$10.4M	Sell	203,142 -995,168	-83%	-$48.4M	0.8%	27
2020 Q1	$52.4M	Buy	1,198,310 +993,769	+486%	+$47.6M	6.14%	3
2019 Q4	$10.3M	Buy	204,541 +81,301	+66%	+$3.81M	0.97%	24
2019 Q3	$5.71M	Buy	+123,240	New	+$5.31M	0.54%	33

Other funds holding SNY

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Boston Partners Boston, Massachusetts $113B AUM 38.87% 1-Year Est. Return

Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

CCM

Camber Capital Management Boston, Massachusetts $1.07B AUM 8.19% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Bain Capital Public Equity Management II's SNY Position: Q3 2022 in Review

Bain Capital Public Equity Management II sold out of Sanofi (SNY) in Q3 2022, closing a stake of 1,487,800 shares — an estimated $74.4M sold.

Bain Capital Public Equity Management II first reported a position in SNY in Q3 2019 and held it in 12 quarters. The position peaked at $74.4M in Q2 2022. 588 funds tracked by Wall St. Rank hold SNY as of Q3 2022.

Bain Capital Public Equity Management II reported no remaining Sanofi position as of Q3 2022 after selling out during the quarter.
Bain Capital Public Equity Management II sold 1,487,800 Sanofi shares in Q3 2022, an estimated $74.4M.
Bain Capital Public Equity Management II first reported a position in Sanofi in Q3 2019 and held it in 12 quarters.
Bain Capital Public Equity Management II's Sanofi position peaked at $74.4M in Q2 2022.
588 funds tracked by Wall St. Rank held Sanofi as of Q3 2022.

Based on Bain Capital Public Equity Management II's 13F filing for Q3 2022, filed 14 Nov 2022.